BMI vs ITRI vs FELE vs REZI vs TRMB

For growth investors, Badger Meter, Inc.

(BMI) is the stronger pick with 10. 9% revenue growth year-over-year, versus -3. 0% for Itron, Inc. (ITRI). Itron, Inc. (ITRI) offers the better valuation at 12. 5x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate Resideo Technologies, Inc. (REZI) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Itron, Inc.

(ITRI) is the cheapest at 12. 5x versus Trimble Inc. at 35. 3x. On forward P/E, Resideo Technologies, Inc. is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Badger Meter, Inc. wins at 1. 18x versus Trimble Inc. 's 8. 15x — a reasonable growth-adjusted valuation.

Over the past 5 years, Badger Meter, Inc.

(BMI) delivered a total return of +39. 5%, compared to -22. 0% for Trimble Inc. (TRMB). Over 10 years, the gap is even starker: BMI returned +253. 6% versus REZI's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Badger Meter, Inc.

(BMI) is the lower-risk stock at 0. 87β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately 162% more volatile than BMI relative to the S&P 500. On balance sheet safety, Franklin Electric Co. , Inc. (FELE) carries a lower debt/equity ratio of 21% versus 109% for Resideo Technologies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Badger Meter, Inc.

(BMI) is pulling ahead at 10. 9% versus -3. 0% for Itron, Inc. (ITRI). On earnings-per-share growth, the picture is similar: Itron, Inc. grew EPS 25. 7% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, BMI leads at 17. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Badger Meter, Inc.

(BMI) is the more profitable company, earning 15. 5% net margin versus -7. 1% for Resideo Technologies, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BMI leads at 20. 0% versus 8. 1% for REZI. At the gross margin level — before operating expenses — TRMB leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Badger Meter, Inc. (BMI) is the more undervalued stock at a PEG of 1. 18x versus Trimble Inc. 's 8. 15x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Resideo Technologies, Inc. (REZI) trades at 13. 1x forward P/E versus 27. 3x for Badger Meter, Inc. — 14. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ITRI: 68. 8% to $137. 00.

In this comparison, BMI (1.

2% yield), FELE (1. 1% yield), REZI (0. 6% yield) pay a dividend. ITRI, TRMB do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Badger Meter, Inc.

(BMI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87), 1. 2% yield, +253. 6% 10Y return). Itron, Inc. (ITRI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BMI: +253. 6%, ITRI: +94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BMI (Technology) and ITRI (Technology) and FELE (Industrials) and REZI (Industrials) and TRMB (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BMI is a small-cap quality compounder stock; ITRI is a small-cap deep-value stock; FELE is a small-cap quality compounder stock; REZI is a small-cap quality compounder stock; TRMB is a mid-cap quality compounder stock. BMI, FELE, REZI pay a dividend while ITRI, TRMB do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.